Publikationen in Zusammenarbeit mit Forschern von Erasmus University Medical Center (11)

2022

  1. Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: Final results of the SYNTAX II study

    European Heart Journal, Vol. 43, Núm. 13, pp. 1307-1316

2019

  1. Clinical outcomes of state-of-the-art percutaneous coronary revascularisation in patients with three-vessel disease: Twoyear follow-up of the SYNTAX II study

    EuroIntervention, Vol. 15, Núm. 3, pp. E244-A252

2018

  1. Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

    The Lancet, Vol. 392, Núm. 10151, pp. 940-949

2017

  1. Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study

    European Heart Journal, Vol. 38, Núm. 42, pp. 3124-3134

2014

  1. Comparison of newer-generation drug-eluting with bare-metal stents in patients with acute ST-segment elevation myocardial infarction: A pooled analysis of the EXAMINATION (clinical evaluation of the xience-V stent in acute myocardial INfArcTION) and COMFORTABLE-AMI

    JACC: Cardiovascular Interventions, Vol. 7, Núm. 1, pp. 55-63

  2. Optimization in stent implantation by manual thrombus aspiration in ST-segment-elevation myocardial infarction: Findings from the EXAMINATION trial

    Circulation: Cardiovascular Interventions, Vol. 7, Núm. 3, pp. 294-300

2013

  1. Everolimus-eluting stent versus bare metal stent in proximal left anterior descending ST-elevation myocardial infarction: Insights from the EXAMINATION trial

    American Heart Journal, Vol. 166, Núm. 1

  2. Predictors and clinical implications of stent thrombosis in patients with ST-segment elevation myocardial infarction: Insights from the EXAMINATION trial

    International Journal of Cardiology, Vol. 168, Núm. 3, pp. 2632-2636

2012

  1. Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial

    The Lancet, Vol. 380, Núm. 9852, pp. 1482-1490

2011

  1. Rationale and design of the EXAMINATION trial: A randomised comparison between everolimus-eluting stents and cobalt-chromium bare-metal stents in ST-elevation myocardial infarction

    EuroIntervention, Vol. 7, Núm. 8, pp. 977-984

2005

  1. Management and outcome of patients with established coronary artery disease: The Euro Heart Survey on coronary revascularization

    European Heart Journal, Vol. 26, Núm. 12, pp. 1169-1179